Biomedical Technology Optimization and Dissemination Center (BTOD)
National Institutes of Health (NIH)
Maximum budget of $850,000 in direct costs per year, excluding equipment and consortium F&A costs.
Maximum project period of 5 years, with a total funding limit of 15 years including previous support.
To support late-stage technology optimization and sustainable dissemination of biomedical technologies.
Encourages engagement with the biomedical research community.
Biomedical research community.
Researchers and institutions involved in technology development.
Eligible organization types include higher education institutions, nonprofits, for-profit organizations, local and state governments, and tribal governments.
Non-domestic (non-U.S.) entities are not eligible to apply.
Applications are open to U.S. organizations only; foreign institutions are not eligible.
Projects must focus on late-stage technology optimization and dissemination.
Technologies must have demonstrated feasibility and utility for addressing biomedical questions.
Maximum budget of $850,000 in direct costs per year.
No cost-sharing is required.
Applications are due by January 27, 2026.
The earliest start date for funded projects is May 26, 2023.
Centers can receive support for a maximum of 15 years, including previous funding from related programs.
Applications must follow the SF424 (R&R) Application Guide.
Specific instructions for BTOD Center applications must be adhered to.
Applications will be evaluated based on significance, investigator qualifications, innovation, approach, and environment.
Applications will undergo peer review and receive a written critique.
Funding decisions will be based on scientific merit and relevance to program priorities.
Priority will be given to applications addressing high-priority NIGMS research areas.
Centers must engage with the biomedical research community and demonstrate broad utility of technologies.
Non-domestic components of U.S. organizations are not eligible to apply.
Collaboration with industrial partners is encouraged.
Centers must demonstrate a clear path toward commercialization of technologies.
Strong community engagement and collaboration with diverse research teams.
Failure to demonstrate broad utility and feasibility of technologies.
Consult with NIGMS staff prior to application submission to ensure alignment with program goals.
Highlight unique features of the proposed technology and its potential impact on biomedical research.